Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

PPD Paid $77 Million to Acquire BioDuro

publication date: Nov 30, 2009
In reporting that it has closed its acquisition of BioDuro, PPD, Inc. announced it paid $77 million for BioDuro. The price was not previously released, nor has PPD disclosed the annual revenues of privately held BioDuro. PPD did say that, post-acquisition, it has nearly 1,000 employees in China. Of these, almost 660 came from BioDuro. The company now claims to be the largest CRO in China offering both clinical development and discovery services. More details...
Stock Symbol: (NSDQ: PPDI)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here